ZACHARY BALLARD: Open Payments
NPI 1033643176 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,788 in 253 payments from 15 companies in 2025. Trend: 2023 $2,609 · 2024 $3,259 · 2025 $3,788
Food & beverage: $3,788
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 39 | $645 |
| E.R. Squibb & Sons, L.L.C. | 45 | $564 |
| Vanda Pharmaceuticals Inc. | 18 | $526 |
| ABBVIE INC. | 44 | $521 |
| Alkermes, Inc. | 27 | $324 |
| Lundbeck LLC | 22 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $242 |
| Axsome Therapeutics, Inc. | 11 | $213 |
| Otsuka America Pharmaceutical, Inc. | 13 | $180 |
| Janssen Pharmaceuticals, Inc | 8 | $164 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, ARISTADA, REXULTI, FANAPT, HETLIOZ, CAPLYTA.
Industry payments across OH — which companies pay providers there.
